Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 62,870 | 29,523 | -7,419 | -21,520 | 36,741 |
| Depreciation Amortization | 35,335 | 25,859 | 17,298 | 8,532 | 32,453 |
| Income taxes - deferred | 3,464 | 15,904 | 630 | -7,261 | 16,493 |
| Accounts receivable | -64,351 | 1,749 | -40,884 | -5,225 | 21,405 |
| Accounts payable and accrued liabilities | 4,749 | 1,902 | 2,062 | 1,102 | -9,279 |
| Other Working Capital | -67,846 | -32,823 | -75,332 | -45,584 | 13,541 |
| Other Operating Activity | 68,296 | -725 | 40,275 | 4,083 | 964 |
| Operating Cash Flow | $42,517 | $41,389 | $-63,370 | $-65,873 | $112,318 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -44,812 | -33,631 | -19,681 | -9,082 | -30,673 |
| Net Acquisitions | -650 | N/A | N/A | N/A | -179,379 |
| Investing Cash Flow | $-45,462 | $-33,631 | $-19,681 | $-9,082 | $-210,052 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,000 | 2,000 | 2,000 | N/A | 242,588 |
| Debt Repayment | N/A | N/A | N/A | N/A | -62,000 |
| Common Stock Issued | 25,961 | 15,902 | 13,162 | 6,344 | 14,078 |
| Common Stock Repurchased | -100 | N/A | N/A | N/A | -200 |
| Other Financing Activity | 7,530 | 2,575 | 2,239 | 4,652 | 4,408 |
| Financing Cash Flow | $35,391 | $20,477 | $17,401 | $10,996 | $198,874 |
| Exchange Rate Effect | -150 | -16 | -8 | -25 | 21 |
| Beginning Cash Position | 280,499 | 280,499 | 280,499 | 280,499 | 179,338 |
| End Cash Position | 312,795 | 308,718 | 214,841 | 216,515 | 280,499 |
| Net Cash Flow | $32,296 | $28,219 | $-65,658 | $-63,984 | $101,161 |
| Free Cash Flow | |||||
| Operating Cash Flow | 42,517 | 41,389 | -63,370 | -65,873 | 112,318 |
| Capital Expenditure | -44,812 | -33,631 | -19,681 | -9,082 | -30,673 |
| Free Cash Flow | -2,295 | 7,758 | -83,051 | -74,955 | 81,645 |